A Review Of Prostate Specific Antigen Use In Screening For Prostate Cancer

Screening for prostate cancer using prostate specific antigen (PSA) testing continues to be problematic. Even though it is unproven whether population-wide screening with PSA can reduce death, illness or disability from prostate cancer, testing has become common in North America. A recent nation-wide survey indicates almost half of Canadian men over 50 years old are tested during their lifetime. In this review, Drs. [click link for full article]

More: continued here

Filed under: Prostate on July 2nd, 2007